Brilinta Launch Website

Brand: Brilinta (ticagrelor), Tablets
Parent Company: AstraZeneca
Drug Type: Boxed Warning
Drug Category: Cardiovascular
Campaign: Launch
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.brilinta.com/
HCP Website: https://www.brilintatouchpoints.com/